Meeder Asset Management Inc Corcept Therapeutics Inc Transaction History

Meeder Asset Management Inc

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $642 - $757	-26 Reduced 29.55%	62 $2,000
Q2 2022 Aug 08, 2022	SELL	$17.33 - $25.3 $693 - $1,012	-40 Reduced 31.25%	88 $2,000
Q1 2022 May 10, 2022	BUY	$16.53 - $25.21 $2,115 - $3,226	128 New	128 $3,000
Q4 2021 Feb 11, 2022	SELL	$17.1 - $23.34 $803 - $1,096	-47 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$19.68 - $22.53 $1,338 - $1,532	-68 Reduced 59.13%	47 $1,000
Q2 2021 Aug 09, 2021	BUY	$19.97 - $24.43 $239 - $293	12 Added 11.65%	115 $3,000
Q1 2021 Apr 28, 2021	BUY	$23.49 - $30.56 $1,973 - $2,567	84 Added 442.11%	103 $2,000
Q4 2020 Feb 09, 2021	SELL	$16.78 - $27.3 $153,822 - $250,259	-9,167 Reduced 99.79%	19 $0
Q3 2020 Nov 02, 2020	BUY	$12.46 - $19.98 $114,270 - $183,236	9,171 Added 61140.0%	9,186 $159,000
Q2 2020 Aug 11, 2020	BUY	$11.0 - $18.26 $165 - $273	15 New	15 $0
Q1 2019 Apr 16, 2019	SELL	$10.03 - $15.71 $6,118 - $9,583	-610 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$11.29 - $17.19 $1,614 - $2,458	143 Added 30.62%	610 $8,000
Q3 2018 Nov 02, 2018	SELL	$12.27 - $15.65 $12,220 - $15,587	-996 Reduced 68.08%	467 $0
Q2 2018 Jul 24, 2018	SELL	$15.3 - $19.69 $8,017 - $10,317	-524 Reduced 26.37%	1,463 $0
Q1 2018 May 03, 2018	SELL	$14.59 - $25.5 $6,186 - $10,812	-424 Reduced 17.59%	1,987 $33,000
Q4 2017 Feb 02, 2018	BUY	$15.77 - $20.72 $24,049 - $31,598	1,525 Added 172.12%	2,411 $43,000
Q3 2017 Oct 20, 2017	BUY	$12.3 - $19.3 $10,897 - $17,099	886	886 $17,000

403

84.3M

1.04M

1.33M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.81B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.